Decision Makers' Needs as Capacities to Benefit
Do Decision Makers Really Need Health Economic Data?
Use of Pharmacoeconomics Information—Report of the ISPOR Task Force on Use of Pharmacoeconomic/Health Economic Information in Health-Care Decision Making
Cost-Effectiveness Analysis in Health Policy
Risk Management
Cost-Effectiveness Analysis of Pharmaceutical Care in a Medicare Drug Benefit Program
Cost-Effectiveness of Migraine Treatment
A Cost-Effectiveness Analysis of Eletriptan 40 and 80 mg versus Sumatriptan 50 and 100 mg in the Acute Treatment of Migraine
Seasonal versus Perennial Allergic Rhinitis
Cost Implications of Administering Intravenous Proton Pump Inhibitors to All Patients Presenting to the Emergency Department with Peptic Ulcer Bleeding
The Impact of Including Passive Benefits in Cost-Effectiveness Analysis
Using Stated Preference Modeling to Forecast the Effect of Medication Attributes on Prescriptions of Alcoholism Medications
Assessment of Respondent Acceptability of Preference Measures
Future Burden and Costs of Smoking-Related Disease in the Netherlands